End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.48 CNY | +1.15% |
|
-1.03% | +12.77% |
05:37am | Second Chinese drugmaker seeks approval for Ozempic generic | RE |
Jun. 13 | Sihuan Pharma Subsidiary Licenses Fadanafil Drug to Livzon Pharmaceutical Unit | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.77% | 4.38B | |
+50.80% | 795B | |
+41.96% | 627B | |
-7.20% | 350B | |
+18.63% | 328B | |
+9.18% | 294B | |
+18.02% | 245B | |
+1.27% | 222B | |
+11.95% | 215B | |
+3.60% | 160B |
- Stock Market
- Equities
- 000513 Stock
- News Livzon Pharmaceutical Group Inc.
- Livzon Pharmaceutical Group Inc. Provides Earnings Guidance for the Six Months Ended June 30, 2017